Insulin Lispro-aabc Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Insulin Lispro-aabc Injection (injection) from Eli Lilly And Co. with status No longer listed by FDA. The shortage was first posted on Oct 24, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Eli Lilly And Co.
- Package NDC
- 0002-8235-05
- Dosage Form
- Injection
- Presentation
- Lyumjev, Injection, U-100 Tempo Pen (NDC 0002-8235-05)
- Initial Posting
- Oct 24, 2025